Archive for the ‘TrovaGene Inc’ Category

Trovagene Inc

July 25th, 2013 | Posted in TrovaGene Inc

Trovagene Inc. – announced the issuance of a broad patent that covers methods of detecting cell-free microRNA in urine and blood, which are known to play critical roles in cell development as well as a number of diseases, including cancer.

Trovagene Inc

July 10th, 2012 | Posted in 2012, TrovaGene Inc

Trovagene Inc. – San Diego:  Is a developer of trans-renal molecular diagnostics.  The company recently announced that it will collaborate with the University of Texas’s Anderson Cancer Center on the detection of trans-renal KRAS mutations in the urine of patients with pancreatic cancer.

Trovagene Inc

February 21st, 2012 | Posted in 2012, TrovaGene Inc

Trovagene Inc. – San Diego:  A developer of transrenal molecular diagnostics, named Charlie Rodi as Vice President and Chief Technology Officer (CTO).  Rodi is the recipient of several National Institutes of Health Grants to fight infectious diseases.

TrovaGene Inc

March 4th, 2010 | Posted in TrovaGene Inc

TrovaGene Inc., formerly Xenomics, a transrenal molecular diagnostics company, has relocated to San Diego.  The company has leased a 5,000-square-foot facility in the Sorrento Valley area.  The company is in the process of completing all of the necessary laboratory validations.